SONX · Sonendo, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $33.20M | $43.87M | $41.66M | $23.35M |
| Cost of Revenue | $19.86M | $31.18M | $31.18M | $19.47M |
| Gross Profit | $11.84M | $10.72M | $10.48M | $3.88M |
| R&D | $6.76M | $12.36M | $16.78M | $20.46M |
| SG&A | $17.35M | $54.02M | $51.91M | $26.70M |
| Total Operating Expenses | $41.21M | $68.47M | $68.68M | $46.68M |
| D&A | $288.0K | $1.12M | $1.05M | $2.08M |
| Operating Income | ($29.37M) | ($57.74M) | ($58.20M) | ($42.80M) |
| Interest Expense | $5.47M | - | - | - |
| Income Tax | $2.0K | $2.0K | $2.0K | $2.0K |
| Net Income | ($28.03M) | ($60.92M) | ($57.05M) | ($46.66M) |
| EPS - Basic | ($59.03) | ($26000.00) | ($340800.00) | - |
| EPS - Diluted | ($59.03) | ($26000.00) | ($340800.00) | - |
Balance Sheet
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash & Equivalents | $10.23M | $14.01M | $17.66M | $84.64M |
| Accounts Receivable | $3.68M | $5.08M | $5.80M | $2.52M |
| Inventory | $10.21M | $11.07M | $15.46M | $8.15M |
| Accounts Payable | $1.96M | $1.18M | $4.44M | $3.06M |
| Current Assets | $27.80M | $65.27M | $121.11M | $98.86M |
| Total Assets | $31.27M | $78.16M | $137.28M | $115.50M |
| Current Liabilities | $19.94M | $35.32M | $16.72M | $14.65M |
| Long-term Debt | $3.64M | $12.47M | $36.75M | $26.50M |
| Total Liabilities | $26.07M | $49.74M | $55.33M | $43.44M |
| Stockholders' Equity | $5.19M | $28.42M | $81.95M | $72.06M |
| Retained Earnings | ($458.05M) | ($430.01M) | ($369.09M) | ($312.04M) |
Cash Flow
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Operating Cash Flow | ($24.65M) | ($46.06M) | ($61.07M) | ($38.54M) |
| Investing Cash Flow | $45.81M | $42.40M | ($74.43M) | ($916.0K) |
| Financing Cash Flow | ($24.95M) | $4.0K | $68.53M | ($983.0K) |
| CapEx | $161.0K | $929.0K | $1.36M | $916.0K |
| Free Cash Flow | ($24.81M) | ($46.99M) | ($62.43M) | ($39.46M) |
Ratios
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Profitability | ||||
| Gross margin | 35.7% | 24.4% | 25.2% | 16.6% |
| Operating margin | -88.5% | -131.6% | -139.7% | -183.3% |
| EBITDA margin | -87.6% | -129.1% | -137.2% | -174.4% |
| Net margin | -84.4% | -138.9% | -137.0% | -199.8% |
| Free cash flow margin | -74.7% | -107.1% | -149.9% | -169.0% |
| FCF / Net income | 0.89 | 0.77 | 1.09 | 0.85 |
| R&D / Revenue | 20.4% | 28.2% | 40.3% | 87.6% |
| SG&A / Revenue | 52.3% | 123.2% | 124.6% | 114.3% |
| Effective tax rate | - | - | - | - |
| Return on assets | -89.7% | -77.9% | -41.6% | -40.4% |
| Return on equity | -540.0% | -214.4% | -69.6% | -64.8% |
| Return on invested capital | -262.8% | -111.6% | -38.7% | -34.3% |
| Liquidity | ||||
| Current ratio | 1.39 | 1.85 | 7.24 | 6.75 |
| Quick ratio | 0.88 | 1.53 | 6.32 | 6.19 |
| Cash ratio | 0.51 | 0.40 | 1.06 | 5.78 |
| Leverage | ||||
| Debt / Equity | 0.70 | 0.44 | 0.45 | 0.37 |
| Debt / Assets | 0.12 | 0.16 | 0.27 | 0.23 |
| Debt / EBITDA | - | - | - | - |
| Interest coverage | -5.4x | - | - | - |
| Equity multiplier | 6.02 | 2.75 | 1.68 | 1.60 |
| Liabilities / Assets | 0.83 | 0.64 | 0.40 | 0.38 |
| Efficiency | ||||
| Asset turnover | 1.06 | 0.56 | 0.30 | 0.20 |
| Inventory turnover | 1.95 | 2.82 | 2.02 | 2.39 |
| Days sales outstanding | 40d | 42d | 51d | 39d |
| Days inventory outstanding | 188d | 130d | 181d | 153d |
| Days payable outstanding | 36d | 14d | 52d | 57d |
| Cash conversion cycle | 192d | 158d | 180d | 135d |
| Valuation | ||||
| P / E | - | - | - | - |
| P / B | 0.2x | 138.9x | 39.3x | - |
| P / S | 0.0x | 90.0x | 77.4x | - |
| EV / EBITDA | - | - | - | - |
| Growth | ||||
| Revenue growth (YoY) | -24.3% | 5.3% | 78.4% | - |
| Revenue CAGR (3y) | 12.4% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - |
| Gross profit growth (YoY) | 10.4% | 2.3% | 169.8% | - |
| Operating income growth (YoY) | 49.1% | 0.8% | -36.0% | - |
| Net income growth (YoY) | 54.0% | -6.8% | -22.3% | - |
| EPS growth (YoY) | 99.8% | 92.4% | - | - |
| EPS CAGR (3y) | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - |
| FCF growth (YoY) | 47.2% | 24.7% | -58.2% | - |
| FCF CAGR (5y) | - | - | - | - |
| Book value growth (YoY) | -81.7% | -65.3% | 13.7% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-12-31.
Product / service
$30.25M totalProduct$30.25M · 100.0%
Stability scores
Altman Z′
FY 2024 · bankruptcy risk
-14.00
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2024 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Dental Equipment & Supplies
Comparing Sonendo against the 5 most active filers in the same SIC group.